• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, January 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Carl F. Ware receives ICIS Honorary Lifetime Membership Award

Bioengineer by Bioengineer
September 6, 2025
in Biology
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

LA JOLLA, CALIF. – June 29, 2021 – Carl F. Ware, Ph.D., director of the Inflammatory Diseases Center at Sanford Burhnam Prebys, has received the 2021 International Cytokine & Interferon Society Honorary Lifetime Membership Award. The award is a tribute to his seminal and original contributions to our understanding of the role of cytokines in immunology and active engagement in cytokine research.

“It’s a tremendous honor to receive this prestigious award,” says Ware. “I’m grateful for the many outstanding scientists and students I’ve worked with over the years who have contributed to the field of cytokines. It’s especially gratifying to see how our discoveries are now being translated into much-needed therapies for infectious and inflammatory diseases–and even cancer.”

Ware began studying cytokines as a graduate student in the early 1970s. His decades-long career has produced many scientific breakthroughs, including the discoveries of several cytokines controlling immune defenses to viral infections. Recently, Ware showed that LIGHT levels are increased in COVID-19 patients progressing to pneumonia, which launched a Phase 2 trial using a LIGHT antibody that he developed.

With continuous support from the National Institutes of Health, Ware continues to investigate cytokine networks as a source of therapeutics for diseases without effective treatment. His work is providing new insights into immune evasion mechanisms and novel approaches to treat persistent viral infections. He is the holder of 18 patents, including one recently licensed to develop a new drug for patients with autoimmune diseases.

Among his several positions, he served with distinction as president of the International Cytokine Society and is on the scientific advisory board of the International Congress on TNF-related cytokines for many years. He has served on numerous advisory boards and study sections including the editorial board of the Journal of Interferon and Cytokine Research from 1996 to the present. In addition to his many scientific achievements, Ware has an outstanding record of mentorship with trainees who continue to shape the cytokine field all over the world.

###

About Sanford Burnham Prebys Medical Research Institute

Sanford Burnham Prebys is a preeminent, independent biomedical research institute dedicated to understanding human biology and disease and advancing scientific discoveries to profoundly impact human health. For more than 40 years, our research has produced breakthroughs in cancer, neuroscience, immunology and children’s diseases, and is anchored by our NCI-designated Cancer Center and advanced drug discovery capabilities. For more information, visit us at SBPdiscovery.org or on Facebook at facebook.com/SBPdiscovery and on Twitter @SBPdiscovery.

Media Contact
Susan Gammon
[email protected]

Tags: BiologyBiotechnologyCell BiologyImmunology/Allergies/Asthma
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Decoding Corvid Calls: Challenges and Opportunities Ahead

January 19, 2026
Dogs Demonstrate Same-Different Odor Learning Abilities

Dogs Demonstrate Same-Different Odor Learning Abilities

January 18, 2026

Do Asian Elephants Strategize for Conflicting Outcomes?

January 18, 2026

Tracking Fungal Pathogen Evolution Through Comparative Genomics

January 18, 2026
Please login to join discussion

POPULAR NEWS

  • Enhancing Spiritual Care Education in Nursing Programs

    155 shares
    Share 62 Tweet 39
  • PTSD, Depression, Anxiety in Childhood Cancer Survivors, Parents

    148 shares
    Share 59 Tweet 37
  • Robotic Ureteral Reconstruction: A Novel Approach

    78 shares
    Share 31 Tweet 20
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    54 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Precision of 3D-Printed Guides Post-Sterilization: Material Comparison

Quality Control Mechanisms at Stalled Ribosomes

Immune Evasion in Colorectal Cancers: Tumor Insights

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 71 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.